Publication Name	World Journal of Gastroenterology
Manuscript ID	73205
Country	United States

Received	2021-11-13 19:45
Peer-Review Started	2021-11-13 19:47
To Make the First Decision
Return for Revision	2022-01-09 06:05
Revised	2022-01-22 03:34
Second Decision	2022-03-18 06:18
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2022-03-27 05:28
Articles in Press	2022-03-27 05:28
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2022-04-24 06:11
Publish the Manuscript Online	2022-05-12 08:42

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Novel drug delivery systems for inflammatory bowel disease
Manuscript Source	Invited Manuscript
All Author List	Farah Yasmin, Hala Najeeb, Shehryar Shaikh, Muhammad Hasanain, Unaiza Naeem, Abdul Moeed, Thoyaja Koritala, Syedadeel Hasan and Salim Surani
Funding Agency and Grant Number
Corresponding Author	Salim Surani, FACP, FCCP, MD, MSc, Doctor, Professor, Medicine, Texas A&M University, 400 Bizzell St, College Station,, College Station, Texas 77843, United States. srsurani@hotmail.com
Key Words	Inflammation; Inflammatory bowel diseases; Colitis; Ulcerative; Crohn’s disease; Drug delivery systems; Drug carrier
Core Tip	Current literature on novel drug delivery systems is extensive. However, limited content is available that focuses on the novel drug delivery strategies, focally the enteric-coated microneedles pills and biological drug delivery systems. In our review, we discuss multiple novel approaches comprehensively, after outlining the disease course in inflammatory bowel diseases (IBD) and how the conventional routes of drug administrations are deficient in addressing some aspects of disease treatment. We specify that novel carrier systems can be considered for targeting inflamed sites in IBD and discuss the implications of choosing such routes.
Publish Date	2022-05-12 08:42
Citation	Yasmin F, Najeeb H, Shaikh S, Hasanain M, Naeem U, Moeed A, Koritala T, Hasan S, Surani S. Novel drug delivery systems for Inflammatory bowel disease. World J Gastroenterol 2022; 28(18): 1922-1933
URL	https://www.wjgnet.com/1007-9327/full/v28/i18/1922.htm
DOI	https://dx.doi.org/10.3748/wjg.v28.i18.1922

Full Article (PDF)	WJG-28-1922.pdf
Full Article (Word)	WJG-28-1922.docx
Manuscript File	73205_Auto_Edited.docx
Answering Reviewers	73205-Answering reviewers.pdf
Audio Core Tip	73205-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	73205-Conflict-of-interest statement.pdf
Copyright License Agreement	73205-Copyright license agreement.pdf
Peer-review Report	73205-Peer-review(s).pdf
Scientific Misconduct Check	73205-Bing-Wu YXJ-2.png
Scientific Editor Work List	73205-Scientific editor work list.pdf